Tudorza Pressair (Forest Laboratories, Inc.)


Welcome to the PulseAid listing for the Tudorza Pressair drug offered from Forest Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Forest Laboratories, Inc.
NON-PROPRIETARY NAME: aclidinium bromide
SUBSTANCE NAME: ACLIDINIUM BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: INHALANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-07-23
END MARKETING DATE: 0000-00-00


Tudorza Pressair HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTudorza Pressair from Forest Laboratories, Inc.
LABELER NAME: Forest Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 400(ug/1)
START MARKETING DATE: 2012-07-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0456-0800_177891db-f2cf-40a5-af72-20c758e4deaf
PRODUCT NDC: 0456-0800
APPLICATION NUMBER: NDA202450

Other ACLIDINIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPTudorza Pressair
Forest Laboratories, Inc.Tudorza Pressair